Skip to content

Generate Biomedicines, Inc. GENB Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

MYR Group logo
MYR GroupMYRG
$8.38M-42.1%
NNN REIT logo
NNN REITNNN
$100.58M+1.7%
Repligen logo
RepligenRGEN
$16.76M-1.9%
SSR Mining logo
SSR MiningSSRM
$52.11M+88.9%
ST
Sensata TechnologiesST
$78.2M+1.4%
AppFolio logo
AppFolioAPPF
$5.99M-22.0%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's other non-current liabilities?
Generate Biomedicines, Inc. (GENB) reported other non-current liabilities of $0 in Q1 2026.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.